NLS Pharmaceutics
NLSP
NLSP
4 hedge funds and large institutions have $467K invested in NLS Pharmaceutics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$7.28K |
| 2 |
CA
CoreCap Advisors
Southfield,
Michigan
|
+$104 |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$31.2K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BI
1
BVF Inc
San Francisco,
California
| $417K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $43.4K | -$31.2K | -10,755 | -42% |
|
|
3
Morgan Stanley
New York
| $7.28K | +$7.28K | +2,510 | New |
|
|
CA
4
CoreCap Advisors
Southfield,
Michigan
| $104 | +$104 | +36 | New |
|